Zurich Cantonal Bank’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.78M | Buy |
+6,370
| New | +$1.83M | ﹤0.01% | 1102 |
|
|
2025
Q4 | – | Sell |
-4,195
| Closed | -$1.31M | – | 2684 |
|
|
2025
Q3 | $1.18M | Hold |
4,195
| – | – | ﹤0.01% | 1191 |
|
|
2025
Q2 | $1.01M | Sell |
4,195
-12,245
| -74% | -$2.89M | ﹤0.01% | 1222 |
|
|
2025
Q1 | $4M | Buy |
16,440
+5,852
| +55% | +$1.76M | 0.01% | 632 |
|
|
2024
Q4 | $3.48M | Buy |
10,588
+4,256
| +67% | +$1.44M | 0.01% | 685 |
|
|
2024
Q3 | $2.12M | Buy |
6,332
+511
| +9% | +$162K | 0.01% | 780 |
|
|
2024
Q2 | $1.59M | Buy |
5,821
+2,540
| +77% | +$739K | 0.01% | 830 |
|
|
2024
Q1 | $1.13M | Sell |
3,281
-79
| -2% | -$26K | ﹤0.01% | 1000 |
|
|
2023
Q4 | $1.08M | Sell |
3,360
-9,767
| -74% | -$3.06M | ﹤0.01% | 1020 |
|
|
2023
Q3 | $4.71M | Buy |
13,127
+140
| +1% | +$54K | 0.02% | 521 |
|
|
2023
Q2 | $4.92M | Buy |
12,987
+144
| +1% | +$58.6K | 0.02% | 515 |
|
|
2023
Q1 | $6.15M | Sell |
12,843
-89
| -0.7% | -$41.7K | 0.03% | 445 |
|
|
2022
Q4 | $5.44M | Buy |
12,932
+9,828
| +317% | +$3.97M | 0.03% | 463 |
|
|
2022
Q3 | $1.29M | Buy |
3,104
+145
| +5% | +$72.3K | 0.01% | 778 |
|
|
2022
Q2 | $1.47M | Sell |
2,959
-1,071
| -27% | -$558K | 0.01% | 744 |
|
|
2022
Q1 | $2.27M | Buy |
4,030
+173
| +4% | +$104K | 0.01% | 693 |
|
|
2021
Q4 | $2.91M | Sell |
3,857
-663
| -15% | -$496K | 0.01% | 655 |
|
|
2021
Q3 | $3.37M | Buy |
4,520
+150
| +3% | +$112K | 0.02% | 617 |
|
|
2021
Q2 | $2.82M | Buy |
4,370
+329
| +8% | +$200K | 0.02% | 641 |
|
|
2021
Q1 | $2.31M | Buy |
4,041
+356
| +10% | +$211K | 0.01% | 669 |
|
|
2020
Q4 | $2.15M | Sell |
3,685
-2,246
| -38% | -$1.28M | 0.01% | 719 |
|
|
2020
Q3 | $3.06M | Buy |
5,931
+824
| +16% | +$417K | 0.02% | 582 |
|
|
2020
Q2 | $2.31M | Buy |
5,107
+81
| +2% | +$35.7K | 0.02% | 600 |
|
|
2020
Q1 | $1.76M | Buy |
5,026
+222
| +5% | +$81.6K | 0.02% | 634 |
|
|
2019
Q4 | $1.78M | Buy |
4,804
+3,500
| +268% | +$1.23M | 0.01% | 698 |
|
|
2019
Q3 | $434K | Buy |
1,304
+81
| +7% | +$26.4K | ﹤0.01% | 942 |
|
|
2019
Q2 | $382K | Hold |
1,223
| – | – | ﹤0.01% | 979 |
|
|
2019
Q1 | $374K | Sell |
1,223
-208
| -15% | -$56.1K | ﹤0.01% | 957 |
|
|
2018
Q4 | $332K | Buy |
1,431
+172
| +14% | +$46.1K | ﹤0.01% | 986 |
|
|
2018
Q3 | $394K | Buy |
1,259
+94
| +8% | +$29.2K | ﹤0.01% | 988 |
|
|
2018
Q2 | $336K | Hold |
1,165
| – | – | ﹤0.01% | 1006 |
|
|
2018
Q1 | $291K | Hold |
1,165
| – | – | ﹤0.01% | 1027 |
|
|
2017
Q4 | $278K | Buy |
1,165
+350
| +43% | +$84.8K | ﹤0.01% | 1020 |
|
|
2017
Q3 | $181K | Hold |
815
| – | – | ﹤0.01% | 1055 |
|
|
2017
Q2 | $184K | Buy |
815
+90
| +12% | +$19.6K | ﹤0.01% | 1030 |
|
|
2017
Q1 | $145K | Hold |
725
| – | – | ﹤0.01% | 1127 |
|
|
2016
Q4 | $132K | Hold |
725
| – | – | ﹤0.01% | 1138 |
|
|
2016
Q3 | $119K | Buy |
725
+83
| +13% | +$12.6K | ﹤0.01% | 1152 |
|
|
2016
Q2 | $92K | Hold |
642
| – | – | ﹤0.01% | 1191 |
|
|
2016
Q1 | $88K | Buy |
642
+182
| +40% | +$23.9K | ﹤0.01% | 1193 |
|
|
2015
Q4 | $64K | Buy |
460
+193
| +72% | +$26.8K | ﹤0.01% | 1318 |
|
|
2015
Q3 | $36K | Buy |
267
+212
| +385% | +$30.5K | ﹤0.01% | 1263 |
|
|
2015
Q2 | $8K | Hold |
55
| – | – | ﹤0.01% | 1518 |
|
|
2015
Q1 | $7K | Buy |
+55
| New | +$6.82K | ﹤0.01% | 1584 |
|
Other funds holding BIO
VCM
VPM
AI
